NF1 and lung carcinoma: Previous studies demonstrated that KRAS mutation had a negative prognostic impact, especially in early stage lung cancer.26, 27 Here, we observed that NF1‐mutated patients showed significantly increased DFS and OS vs KRAS‐mutated patients in univariate analysis (Figure 3).